by Jimmy Carter | Jun 18, 2019 | Alzheimer’s
A connection between Neurofilament light (NfL) levels present in the blood and Alzheimer’s disease was recently made in a study released by the JAMA Network. This discovery could lead to a simple blood test that has the ability to detect the levels of conditions...
by Jimmy Carter | May 23, 2019 | Chronic Traumatic Encephalopathy (CTE)
A recent study published in the New England Journal of medicine revealed that brain scans of more than two dozen former NFL players found that the men had abnormal levels of the protein linked to chronic traumatic encephalopathy (C.T.E.), the degenerative brain...
by Jimmy Carter | May 15, 2019 | Alzheimer’s
There have long been debates among established medical authorities and supplement manufacturers, especially when it comes to treating cognitive decline. Are the myriad of supplements currently on the market a genie in a bottle? Or is it better to focus on leading a...
by Jimmy Carter | Apr 23, 2019 | Alzheimer’s
Another big blow came to the Alzheimer’s research community late last month when pharmaceutical company Biogen and Eisai Co. announced on March 22 that they would terminate two late-stage studies of the experimental drug aducanumab. They have ceased trials after they...
by Jimmy Carter | Apr 8, 2019 | Alzheimer’s
That’s what a recent study conducted at the Duke Eye Center suggests. The study of more than 200 people, published on March 11 in the journal Ophthalmology Retina, proposes that a quick, noninvasive eye exam might one day allow eye doctors to check up on both your...